Ferric Pyrophosphate Citrate

焦磷酸铁柠檬酸

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameFerric Pyrophosphate Citrate
Drug Alias NameFPC正磷酸铁Triferic AVNU柠檬酸焦磷酸铁枸橼酸焦磷酸铁 +[7] 
ClassificationSmall molecules > Polymers and chelators
Mechanisms of ActionIron replacements
TargetsNot applicable
Therapy Area/IndicationsHemoglobinopathiesAnemia, Iron-DeficiencyAnemia +[6] 
Global Approved IndicationsAnemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2015/01/23
Country/TerritoryCanadaUnited StatesPuerto Rico +[4] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesRockwell Medical Inc
China Registration ClassN/A

Develop Information

Active CompaniesDrogsan PharmaceuticalsJeil Pharmaceutical Co LtdHolopack Verpackungstechnik Gmbh +[5] 
Inactive CompaniesRockwell Medical Technologies Inc
Active IndicationsHemoglobinopathiesRenal Insufficiency, Chronic
Inactive IndicationsAnemia, Iron-DeficiencyAnemiaKidney Failure, Chronic +[4] 

Other Information

ATC CodeB03A
Related LinksDrugBankKEGG